219 related articles for article (PubMed ID: 6772357)
21. The evaluation of the role of androgens in hirsutism and the use of a new anti-androgen "cyproterone acetate" for therapy.
Ismail AA; Davidson DW; Souka AR; Barnes EW; Irvine WJ; Kilimnik H; Vanderbeeken Y
J Clin Endocrinol Metab; 1974 Jul; 39(1):81-95. PubMed ID: 4835125
[No Abstract] [Full Text] [Related]
22. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
23. Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism.
Pugeat M; Forest MG; Nisula BC; Corniau J; De Peretti E; Tourniaire J
Obstet Gynecol; 1982 Jan; 59(1):46-51. PubMed ID: 6804896
[TBL] [Abstract][Full Text] [Related]
24. The polycystic ovary syndrome. 1. Pathogenesis.
White MC; Turner EI
Br J Hosp Med; 1994 Feb 16-Mar 1; 51(4):167-74. PubMed ID: 8012678
[TBL] [Abstract][Full Text] [Related]
25. Understanding the polycystic ovary syndrome.
Givens JR; Kurtz BR
Prog Clin Biol Res; 1986; 225():355-76. PubMed ID: 3097672
[No Abstract] [Full Text] [Related]
26. Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome.
Kamel N; Tonyukuk V; Emral R; Corapçioğlu D; Baştemir M; Güllü S
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):115-21. PubMed ID: 15772904
[TBL] [Abstract][Full Text] [Related]
27. Endocrinologic aspects of dysfunctional uterine bleeding.
Sobrinho LG; Kase N
Clin Obstet Gynecol; 1970 Jun; 13(2):400-15. PubMed ID: 4993047
[No Abstract] [Full Text] [Related]
28. Polycystic ovarian disease.
Goldzieher JW
Clin Obstet Gynecol; 1973 Dec; 16(4):82-105. PubMed ID: 4593954
[No Abstract] [Full Text] [Related]
29. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.
Polson DW; Kiddy DS; Mason HD; Franks S
Fertil Steril; 1989 Jan; 51(1):30-4. PubMed ID: 2491994
[TBL] [Abstract][Full Text] [Related]
30. [Polycystic ovary syndrome].
Campodónico I; Cheviakoff S; Devoto L; Glavic A; Porcile A; Reid I
Rev Chil Obstet Ginecol; 1983; 48(1):16-26. PubMed ID: 6681188
[No Abstract] [Full Text] [Related]
31. Peripheral steroid-gonadotropin interactions and diagnostic significance of double-stimulation tests with luteinizing hormone-releasing hormone in polycystic ovarian disease.
Moltz L; Römmler A; Schwartz U; Bidlingmaier F; Hammerstein J
Am J Obstet Gynecol; 1979 Aug; 134(7):813-8. PubMed ID: 380343
[No Abstract] [Full Text] [Related]
32. Pathogenesis and treatment of polycystic ovary disease.
Hutchinson-Williams KA; DeCherney AH
Int J Fertil; 1987; 32(6):421-30. PubMed ID: 2891628
[No Abstract] [Full Text] [Related]
33. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
Gonzalez F; Hatala DA; Speroff L
Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
[TBL] [Abstract][Full Text] [Related]
34. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
[TBL] [Abstract][Full Text] [Related]
35. [Etiopathogenesis of the polycystic ovary syndrome].
Sciarra F; Toscano V; Tosti-Croce C
Minerva Endocrinol; 1987; 12(3):183-90. PubMed ID: 3116379
[No Abstract] [Full Text] [Related]
36. Role of sex-hormone-binding globulin and free sex steroid hormones in hyperandrogenic anovulation.
Ohsawa M; Asai M; Masahashi T; Narita O; Tomoda Y; Matsui N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2081-8. PubMed ID: 2947958
[TBL] [Abstract][Full Text] [Related]
37. Serum gonadotropin levels and ancillary studies in Stein-Leventhal syndrome treated with clomiphene citrate.
Gambrell RD; Greenblatt RB; Mahesh VB
Obstet Gynecol; 1971 Dec; 38(6):850-62. PubMed ID: 5125433
[No Abstract] [Full Text] [Related]
38. The polycystic ovary syndrome: pathogenesis and treatment.
Barnes R; Rosenfield RL
Ann Intern Med; 1989 Mar; 110(5):386-99. PubMed ID: 2492787
[TBL] [Abstract][Full Text] [Related]
39. PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?
Doi SA; Towers PA; Scott CJ; Al-Shoumer KA
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):4-16. PubMed ID: 15596265
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams J; Polson DW; Franks S
Br Med J (Clin Res Ed); 1986 Aug; 293(6543):355-9. PubMed ID: 3089520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
